← Open Payments lookup

ROBERT KAPLAN: Open Payments

NPI 1124101035 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$495 in 19 payments from 9 companies in 2025. Trend: 2023 $763 · 2024 $1,251 · 2025 $495

Food & beverage: $495
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$179
GlaxoSmithKline, LLC.3$84
Bayer Healthcare Pharmaceuticals Inc.4$58
Exact Sciences Corporation2$41
Amgen Inc.2$41
Viatris Specialty LLC1$28
CVRx, Inc.1$25
Abbott Laboratories1$22
Novo Nordisk Inc1$17

Products named: CAPLYTA, Kerendia, TRELEGY ELLIPTA, Cologuard Collection Kit, OTEZLA, SHINGRIX, YUPELRI, Barostim Neo System.

Industry payments across NV — which companies pay providers there.